NEW YORK, Nov. 1, 2022 /PRNewswire/ -- According to the latest market research study published by P&S Intelligence, the BPH treatment market accounted for $11,892.8 million revenue in 2021, which is set to touch $18,837.7 million by 2030, progressing at a 5.2% CAGR from 2021 to 2030. This is owing to the growing cases of BPH, soaring preference for minimally invasive operations, and snowballing investments for research on novel treatments.
As per Medscape, by the age of 60, approximately 50% of the men develop histopathologic BPH. By the age of 85, this percentage rises to 90%.
One way in which BPH management has significantly benefitted from advanced technology is the introduction of procedures that do not require general anesthesia or lengthy hospital stays. The prostate can now be fitted with a cutting-edge mechanical implant, which moves the invading lobes to a better position, to improve urine flow.
Get the sample pages of this report: https://www.psmarketresearch.com/market-analysis/benign-prostatic-hyperplasia-treatment-bph-market/report-sample
Minimally Invasive Procedures Are Gaining Wide Acceptance
Surgery is a superior option to treating BPH with medicine. However, patients tend to choose medication because of the post-operative harm that surgical incisions and burns can cause. Lately, patients' perceptions have changed as a result of the development of minimally invasive techniques, thus giving surgical equipment makers a competitive advantage.
Demand for Alpha-Blockers Rising among Patients
Around 85% of the market share was acquired for drug treatment in 2021. This is due to the rising demand for alpha-blockers, which help facilitate easier urine flow by relaxing the bladder neck muscles and the prostate.
Home Healthcare Settings Will Accumulate More Revenue
Home healthcare settings hold the larger market share, and they will experience a CAGR of over 5% in the coming years. This is owing to the rising number of patients who are being prescribed medications rather than surgical procedures. Additionally, a sizeable section of the populace favors drug-based home therapy over hospital care.
Browse detailed report on Benign Prostatic Hyperplasia Treatment Market Size, Share and Demand Analysis Report 2022-2030
North America Widely Uses BPH Treatment
North America holds a 41% share of the global BPH treatment market. The problem's prevalence is rising, encouraging the use of cutting-edge treatments, including prostatic stenting, laser therapy, and UroLift therapy.
Additionally, there are a number of device and pharmaceutical companies in the region, and they are all keenly interested in undertaking R&D operations to improve the standard of care.
With a CAGR of 6.4%, the APAC region is predicted to grow the quickest. The progress is aided by the expanding standard of living, thriving per capita income and purchasing power, rising urological illness burden, and increasing healthcare investment.
The senior male population in Japan, China, and India is huge and needs constant medical care because of its high tendency for chronic illnesses.
Global Benign Prostatic Hyperplasia Treatment Market Report Coverage
By Type
- Drug Treatment
- Alpha blockers
- 5-alpha reductase inhibitors
- Surgical Treatment
- TURP
- TUMT
- TUNA
- Laser therapy
- Prostatic stenting
- UroLift therapy
- Rezûm therapy
By End User
- Home Healthcare
- Hospitals & Clinics
Regional Analysis
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K
- APAC
- China
- Japan
- India
- South Korea
- LATAM
- Brazil,
- Mexico
- MEA
- South Africa
- Saudi Arabia
Browse More Reports Published by P&S
Global Benign Prostatic Hyperplasia Procedures Size, Growth, Share, and Demand Analysis
US Benign Prostatic Hyperplasia Procedures Size, Growth, Share, and Demand Analysis
Global X-Ray Systems Market Size, Growth, Share, and Demand Analysis, 2030
Global Magnetic Beads Market Size, Growth, Share, and Demand Analysis, 2030
About P&S Intelligence
P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.
Contact:
Prajneesh Kumar
P&S Intelligence
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Follow Us: LinkedIn Twitter
Logo: https://mma.prnewswire.com/media/1224988/P_and_S_Intelligence_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/bph-treatment-market-to-cross-18-837-7-million-value-by-2030-ps-intelligence-301664122.html
